Will you get the second covid 19 vaccine booster?

[DRSAMURAI]

Unfortunately you misinterpreted my statement as criticism. Entirely your choice and I respect that. My caps were my indication of enthusiasm in scheduling the booster vaxx so quickly. I applaud your mask wearing mitigation strategy. I, too, am wearing a mask, N95.

Received #2 COVID booster jab yesterday and a few hours later noted left deltoid muscle injection site soreness which is waning in intensity today. Post vaxx side effects can indicate an immune response which is good. Lack of an adverse response may signal the vaxx "did not take".

 

[MamaBee]

@tyty333 . Thank you very much for posting the tracker by state and county.


@MamaBee, Have you had Moderna for all your previous shots? My husband I both have only had Moderna shots and boosters and were wondering if we should get the Pfizer shot this time. We just sent an email to our doctor asking what they recommend.

Yes @Calliecake We had all Moderna shots. We will probably get the Pfizer one this time. I’m still waffling because it seems it works better if you had Pfizer first and then Moderna.

 

[Arcadian]

If they make it part of the study protocol, yes. if not, no.

 

[DRSAMURAI]

If they make it part of the study protocol, yes. if not, no.

One may be randomized either to the placebo group or active drug group.

 

[seaurchin]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

 

[missy]

@tyty333 thanks for the links. I am wearing my mask for the foreseeable future when I go food shopping or to doctor appointments or public restrooms. It is still a rule we must wear masks at doctor offices and hospitals. And I feel more comfortable wearing one as I know it’s an added layer of protection. An easy one at that. An ounce of prevention and all that jazz. For now.

 

[DRSAMURAI]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

The flu season and its serious ramifications has largely been overlooked due to focus on COVID. Kudos to your health provider for being astute enough to offer the flu shot and for your good decision to take it.

 

[Lookinagain]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

yes, it's a thing. I got the pneumonia vaccine twice I think. Once when I was younger and then once for the older people. I'd have to go back and check and see if that's correct because I was also getting the shingles shots during the same time and that's a two shot regimen.

 

[MamaBee]

My doctor’s nurse just called me tonight. She told me that my doctor said to disregard my high antibody count and get the vaccine. I trust her so I will get mine in a few weeks.

 

[tyty333]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

My doc doesn't do the Pneumonia vax until 65 I think. I think I asked about it at 55 and 60 and I still can't get it.

 

[MamaBee]

I’m still waffling..The nurse did say if I really wanted to I could get another antibody test two months after my last one to see if my antibodies are decreasing. My doctor doesn’t do antibody testing or thinks it should be factored in..but left it up to me. I think I may wait until April 22 and get my next antibody test. My husband can get his too. Then we can make a decision. Who knows..I may just go ahead and get it but something is making me hesitate. I’m starting to agree with Missy after reading tons of articles about waiting until the end of summer so we can get through the fall and winter. There will another wave from BA2 mid April so that does give me pause. I wish it was all cut and dry but it isn’t.

 

[AprilBaby]

Hubs got his 4th shot at cvs Wednesday afternoon and got a headache/ tired Thursday afternoon. All good today! We both have the pneumonia shot. I had pneumonia 3 times when I was under 50. I thought 60 was the recommended age? I think my first pneumonia shot was at 42 and I had to pay for it.

 

[Karl_K]

Im getting mine next week, wifey is busy with work this week.
My lung doc the one I trust most of my doctors on this issue says for me to get all recommended covid vaccines when recommended so I'm going to go ahead.
I would like to be able to get a whole or more variant targeted vaccine but that is not possible this round.

 

[danusia]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

Yes, I knew Pneumonia vax was a thing. Got my 1st one last year when I turned 65 and supposedly there is a different Pneumonia vax you are supposed to get a year later. I feel like a pincushion!

 

[MamaBee]

Info on who should get the pneumonia vaccine..

Worried About Pneumonia? Why the Vaccine Is Your Best Defense

Keeping our lungs healthy is priority-one in today’s climate! The pneumonia vaccine is a step toward ensuring that. Learn more about who benefits most from the vaccine and who should avoid it.

health.clevelandclinic.org

 

[danusia]

I am not sure entirely, but leaning towards getting my 2nd booster, just not sure when. Is the government covering the cost still? If not, I am going on Medicare in June (already 65 just on my DH's insurance and he is retiring end of May.) So do not know if it makes a difference if I get it now with my regular insurance or better if Medicare pays?

DD said she is not getting a 2nd booster as she is still recovering from myocarditis from the 1st booster. She won't have her 2nd echocardiogram until May to see if everything has resolved, though she says the rapid heartbeats are not happening as often. The cardiologist said he is not sure what she should do and many of his colleagues are confused as well when it comes to booster shots.

 

[missy]

I definitely plan on getting a second booster but the question is when.
I want to be protected during fall and winter.

I think yearly boosters are here to stay for Covid.

"

As FDA OKs Another COVID Booster, Some Experts Question Need​

Alicia Ault
March 28, 2022



March 29, 2022 // Editor's note: This article has been revised to include the FDA's decision Tuesday to authorize additional boosters from Moderna and Pfizer.
The US Food and Drug Administration (FDA) today authorized Americans over the age of 50 to receive a second COVID-19 booster shot, even though many top infectious disease experts questioned the need before the agency’s decision.
The FDA granted emergency use authorization for both Pfizer and Moderna to offer the second booster — and fourth shot overall — for adults over 50 as well as those over 18 with compromised immune systems.
The Centers for Disease Control and Prevention (CDC) must still sign off before those doses start reaching American arms. That approval could come at any time.

"The general consensus, certainly the CDC's consensus, is that the current vaccines are still really quite effective against Omicron and this new BA.2 variant in keeping people out of the hospital, and preventing the development of severe disease," William Schaffner, MD, an infectious disease specialist at Vanderbilt University Medical Center in Nashville, Tennessee, said prior to the FDA’s announcement Tuesday.

Of the 217.4 million Americans who are "fully vaccinated," ie, received two doses of either Pfizer or Moderna's vaccines or one dose of the Johnson & Johnson vaccine, only 45% have also received a booster shot, according to the CDC.
"Given that, there's no need at the moment for the general population to get a fourth inoculation," Schaffner told Medscape Medical News. "Our current focus ought to be on making sure that as many people as possible get that [first] booster who are eligible."
Monica Gandhi, MD, an infectious disease specialist at the University of California, San Francisco, agreed that another booster for everyone was unnecessary. The only people who would need a fourth shot (or third, if they had the Janssen vaccine initially) are those over age 65 or 70 years, Gandhi said.

"Older people need those antibodies up high because they're more susceptible to severe breakthroughs," she told Medscape Medical News.

To Boost or Not to Boost​

Daniel Kuritzkes, MD, chief of infectious diseases at Brigham & Women's Hospital in Boston, Massachusetts, said the timing of a booster and who should be eligible depends on what the nation is trying to achieve with its vaccination strategy.

"Is the goal to prevent to any symptomatic infection with COVID-19, is the goal to prevent the spread of COVID-19, or is the goal to prevent severe disease that requires hospitalization?" asked Kuritzkes.

The current vaccine — with a booster — has prevented severe disease, he said.

An Israeli study showed, for instance, that a third Pfizer dose was 93% effective against hospitalization, 92% effective against severe illness, and 81% effective against death.

A just-published, randomized controlled study in the New England Journal of Medicine (NEJM) found that a booster of the Pfizer vaccine was 95% effective against COVID-19 infection and that it did not raise any new safety issues.

A small Israeli study, also published in NEJM, of a fourth Pfizer dose given to healthcare workers found that it prevented symptomatic infection and illness, but that it was much less effective than previous doses — maybe 65% effective against symptomatic illness, the authors write.

Giving Americans another booster now — which has been shown to lose some effectiveness after about 4 months — means it might not offer protection this fall and winter, when there could be a seasonal surge of the virus, Kuritzkes told Medscape Medical News.

And, even if people receive boosters every few months, they are still likely to get a mild respiratory virus infection, he said.
"I'm pretty convinced that we cannot boost ourselves out of this pandemic," said Kuritzkes. "We need to first of all ensure there's global immunization so that all the people who have not been vaccinated at all get vaccinated. That's far more important than boosting people a fourth time."

Booster Confusion​

An April 6 FDA meeting of the agency's Vaccines and Related Biological Products Advisory Committee is still on the docket to discuss additional booster doses.

What the FDA's newest authorizations Tuesday mean for the committee's April 6 meeting is not yet clear. The original agenda said the committee will consider the evidence on safety and effectiveness of the additional vaccine doses and discuss how to set up a process — similar to that used for the influenza vaccine — to be able to determine the makeup of COVID vaccines as new variants emerge. That could lay the groundwork for an annual COVID shot, if needed.

The FDA advisers will not make recommendations nor vote on whether — and which — Americans should get a COVID booster. That is the job of the CDC's Advisory Committee on Immunization Practices (ACIP).

The last time a booster was considered, CDC Director Rochelle Walensky, MD, overrode the ACIP and recommended that all Americans — not just older individuals — get an additional COVID shot.

That past action worries Gandhi, who called it confusing, and said it may have contributed to the fact that less than half of Americans have since chosen to get a booster.

Schaffner predicted the FDA would authorize emergency use for fourth doses of the Pfizer and Moderna vaccines, but he doesn't think the CDC committee will recommend routine use. As we saw before, however, the CDC director does not have to follow the committee's advice.

The members of ACIP "might be more conservative or narrower in scope in terms of recommending who needs to be boosted and when boosting is appropriate," Kuritzkes said.

Gandhi said she's concerned that the FDA's deliberations could be swayed by Moderna and Pfizer's influence and that "pharmaceutical companies are going to have more of a say than they should in the scientific process."

There are similar worries for Schaffner. He said he's "a bit grumpy" that the vaccine makers have been using press releases to argue for boosters.

"Press releases are no way to make vaccine recommendations," Schaffner said, adding that he "would advise [vaccine makers] to sit down and be quiet and let the FDA and CDC advisory committee do their thing."

Moderna Chief Medical Officer Paul Burton, MD, however, told WebMD last week that the signs point to why a fourth shot may be needed.


"We see waning of effectiveness, antibody levels come down, and certainly effectiveness against Omicron comes down in 3 to 6 months," Burton said. "The natural history, from what we're seeing around the world, is that BA.2 is definitely here, it's highly transmissible, and I think we are going to get an additional wave of BA.2 here in the United States."

Another wave is coming, he said, and "I think there will be waning of effectiveness. We need to be prepared for that, so that's why we need the fourth dose."

Supply Issues?​

Meanwhile, the United Kingdom has begun offering boosters to its over age 75 years population, and Sweden's health authority has recommended a fourth shot to people over age 80 years.

That puts pressure on the US — at least on its politicians and policymakers — to, in a sense, keep up, said the infectious disease specialists.

Indeed, the White House has been keeping fourth shots in the news, warning that it is running out of money to ensure that all Americans would have access to one, if recommended.

On March 23, outgoing White House COVID-19 Response Coordinator Jeff Zients said that the federal government had enough vaccine for the immunocompromised to get a fourth dose "and, if authorized in the coming weeks, enough supply for fourth doses for our most vulnerable, including seniors."

But he warned that without congressional approval of a COVID-19 funding package, "We can't procure the necessary vaccine supply to support fourth shots for all Americans."
Zients also noted that other countries, including Japan, Vietnam, and the Philippines had already secured future booster doses and added, "We should be securing additional supply right now."

Schaffner said that while it would be nice to "have a booster on the shelf," the US needs to put more effort into creating a globally-coordinated process for ensuring that vaccines match circulating strains and that they are manufactured on a timely basis.

He said he and others "have been reminding the public that the COVID pandemic may indeed be diminishing and moving into the endemic, but that doesn't mean COVID is over or finished or disappeared."

Schaffner said that it may be that "perhaps we'd need a periodic reminder to our immune system to remain protected. In other words, we might have to get boosted perhaps annually like we do with influenza."

Alicia Ault is a Lutherville, Maryland-based freelance journalist whose work has appeared in publications including JAMA, Smithsonian.com, The New York Times, and The Washington Post. You can find her on Twitter @aliciaault.

Kuritzkes disclosed consulting or speaking fees from GlaxoSmithKline, Janssen, Merck, Moderna, and Pfizer. Gandhi has disclosed no relevant financial relationships.

"

 

[MamaBee]

@missy We’re going to get an antibody test near April 22. That would be two months since my last antibody test. We’ll decide then…If they are high enough we will push it out. I may even get another antibody test during the summer. It would give me peace of mind if my antibodies are still high enough. If mine dropped like a brick..I‘ll get the booster. My husband has his eye on going to games in the fall. He wants to push it way out. We’ll see..

 

[Calliecake]

We heard back from our doctor today. She recommended getting the fourth vaccine. I’m also waffling due to positivity rates being so low in our area.

 

[pearlsngems]

I got my 2nd Moderna booster yesterday and only had a mildly sore arm afterward, just at the injection site. DH is getting his Saturday. Our daughter will get one when it become available for adults younger than 50. We all have risk factors so we're being careful. We still mask in public (indoors), and we have not dined inside a restaurant since last July. Cases have come down in our county-- but not low enough for me to feel safe going to restaurants yet.

 

[missy]

More evidence for mixing and matching mRNA vaccines for boosters.

"

"You can diversify your immune response as much as possible to get maximal protective immunity"​

by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today March 31, 2022

The two mRNA vaccines authorized in the U.S. prompt different immune responses -- and that could suggest a benefit for mixing and matching booster shots, researchers said.
Galit Alter, PhD, of Harvard Medical School in Boston, and colleagues set out to investigate the immune responses driven by three doses of Pfizer or Moderna in a cohort of 73 healthcare workers. Both vaccines induced robust functional humoral immune responses, but there were clear differences, they reported in a paper in Science Translational Medicine.

Moderna appeared to have an advantage in mucosal immunity, as measured by immunoglobulin (Ig) A, while Pfizer had a "really functional IgG response," Alter told MedPage Today.
"The mRNA vaccines are inducing different flavors of immunity," Alter said. "That suggests the immune system is seeing them in slightly different ways. And we know that 'different' is incredibly important for training the immune system."
Clinicians on medtwitter quickly interpreted the findings as supporting mixing and matching mRNA boosters -- a strategy that may become even more relevant as certain groups are now eligible for second boosters.
While that wasn't the intention of the study, Alter said it was a "creative" response and agreed that heterologous boosting could be advantageous, based on these findings.
"By slightly changing the way that the immune system sees the COVID antigen, we could essentially not only improve the overall quality and levels of the antibodies we induce, like the amount of neutralizing antibodies, but it could give us better mucosal immunity, or better affinity maturation," Alter said.

In their study of healthcare workers -- 28 received Moderna and 45 had Pfizer -- Alter and colleagues found that those who received Moderna had higher concentrations of IgA binding titers targeting the receptor binding domain (RBD) and the N-terminal domain (NTD). They also had higher levels of antibodies that elicit neutrophil phagocytosis and natural killer cell activation.
When looking specifically at variants of concern, they again found similarly robust functional antibody responses, but vaccination with Pfizer was associated with an IgM- and IgG-biased profile, whereas Moderna prompted an IgA- and IgG-driven profile, they reported.
Alter and colleagues noted that there's an "emerging appreciation" of the importance of antibody functions aside from neutralization, especially with the rise of new variants. Mutations can affect specific regions on the spike protein targeted by neutralizing antibodies, but functional antibodies can target the whole surface of the spike protein, and thus aren't compromised in the same way.

Earlier data have suggested that mixing and matching vaccines was safe and induced robust immune responses, said Christine Johnston, MD, MPH, of the University of Washington School of Medicine in Seattle, who was involved in an NIH-funded study of various boosting strategies published in the New England Journal of Medicine. That study supported an FDA recommendation in October allowing for mixing and matching boosters.
"It makes sense ... that if you're stimulating slightly different parts of the immune system, you would get better overall coverage from the version of SARS-CoV-2 that's circulating, or from variants that are emerging," Johnston said of the interpretations of Alter's data.
While Moderna "looks a little bit better for IgA," or mucosal immunity, Johnston said, she warned that "we don't know the real correlate of immunity -- the overall profile of immune response that's going to give us the best protection against infection or severe disease."

Because that correlate is still unknown, Alter said, "I think the suggestion [of mixing and matching mRNA vaccines] is brilliant, to get the best of both."
"You can diversify your immune response as much as possible to get maximal protective immunity," Alter said. "And then one day when we have the mechanistic correlate of protection, we'll be able to design vaccines that specifically give you that response."
Johnston said studies are ongoing to determine whether mixing and matching various vaccines can lead to clinical benefit, though these will never be at the same scale as the initial vaccine trials. "It's going to be a hard question to answer," she said.
Robert Schooley, MD, of the University of California San Diego, noted that both mRNA vaccines are "highly efficacious" and that any difference in immune profile, "if real, is not sufficiently great to make a recommendation of one over the other."
"If someone is in line for a booster vaccination," Schooley said, "the vaccines are so similar in efficacy that it would be a mistake to delay being vaccinated with whichever of the two is available."


"

 

[missy]

@missy We’re going to get an antibody test near April 22. That would be two months since my last antibody test. We’ll decide then…If they are high enough we will push it out. I may even get another antibody test during the summer. It would give me peace of mind if my antibodies are still high enough. If mine dropped like a brick..I‘ll get the booster. My husband has his eye on going to games in the fall. He wants to push it way out. We’ll see..

Here is some info you might find helpful. But the bottom line is no one can say for sure.

Herd Immunity Out of Reach? House Caps Insulin $$; First Full Human Genome Map

A daily roundup of news on COVID-19 and the rest of medicine

www.medpagetoday.com

"
Getting an unnecessary shot could, in theory, put you at an immunological disadvantage in another way, by interfering with your immune response to a previous COVID shot or infection. One recent study, set to be published in Cell in April, found that people who received three shots saw their antibody levels rise by a factor of up to 100. But among people who had also gotten COVID—that is, those for whom the booster represented a fourth exposure, rather than a third—the increase was much smaller. That’s an example of the “diminishing returns” problem, which wouldn’t really matter if you cared only about your antibody levels. (A lot plus a little is still more than a lot.) But Wherry, who led the Cell study, told me that the smaller increase might have knock-on effects in other parts of the immune system, and end up limiting the B cells that will react to the virus the next time you encounter it.

Here’s how that works: When you get a booster shot or become sick with COVID after being vaccinated, some of your B cells will enter a structure in the lymphoid tissue called a germinal center, a sort of training camp that produces other, more diverse B cells that can respond to all sorts of invaders. If you leave those training camps alone for long enough, they’ll also produce long-lived plasma cells, which hang out in your bone marrow and manufacture antibodies all the time. But an extra booster shot could interrupt that process, Pepper told me, leaving you without the full, long-term benefit of those plasma cells.

All of this means that the longer you wait between shots, the more durable the protection you get. In animals, Wherry said, the benefits of waiting start to plateau after about six months, but in humans, the optimal delay isn’t known.

All of this means that the longer you wait between shots, the more durable the protection you get. In animals, Wherry said, the benefits of waiting start to plateau after about six months, but in humans, the optimal delay isn’t known. Pepper doesn’t think this drawback would come into play for those who got their third shot at least four months ago, as the CDC recommends. “I don’t think getting a booster is going to disrupt anything,” she said. She also recommended that people wait at least four months after their most recent infection for the same reason. But if you get two boosters within, say, a month, Pepper suspects that you’d end up with less protection in the long run than if you’d gotten only one.

Wherry is more inclined to see a possible trade-off, albeit a small and uncertain one. Even if it’s been at least four months since your last booster or infection, choosing whether to get a shot could mean balancing some short-term protection against infection (largely conferred by antibodies) with some long-term protection against severe disease and death (the domain of B and T cells), he told me. Wherry said that older people should give more weight to the former, because as we age, our B- and T-cell responses tend to slow down. Still, everyone should make that decision with their doctor, taking their own health into account. “A 67-year-old marathon runner with no comorbidities, no health issues, is going to be a very different scenario than a 72-year-old lymphoma patient on immune-modifying drugs.”

 

[MamaBee]

@missy It’s seven months for me..so I’ll just monitor my antibody count even though my doctor said to not take that into consideration. She did leave it to me. I will most likely get the Pfizer this time. I think you had your last one in August? If we got it now I don’t think our immune systems would be overwhelmed. I just want to make sure that it lasts longer.. If my numbers are still very high I would definitely wait…If it starts dropping then I would be comfortable getting the booster. I’m very curious to know what my husband’s antibody count is. What is Greg going to do?

 

[missy]

@missy It’s seven months for me..so I’ll just monitor my antibody count even though my doctor said to not take that into consideration. She did leave it to me. I will most likely get the Pfizer this time. I think you had your last one in August? If we got it now I don’t think our immune systems would be overwhelmed. I just want to make sure that it lasts longer.. If my numbers are still very high I would definitely wait…If it starts dropping then I would be comfortable getting the booster. I’m very curious to know what my husband’s antibody count is. What is Greg going to do?

He will do whatever I decide. I just don't know for sure what is best. I don't think anyone does truly. As I wrote before I would like it to carry us through autumn and winter if possible. We will retest end of April when we see our endocrinologist and wait for the results and decide then. As you wrote if the antibodies are dropping I would be more likely to get the second booster sooner vs later. In the meantime wearing masks and physically distancing as best we can so hopefully our risks are low anyway. I was onboard with getting the first three as soon as we could but I feel less anxious to get this second booster for the reasons I listed.

 

[MamaBee]

He will do whatever I decide. I just don't know for sure what is best. I don't think anyone does truly. As I wrote before I would like it to carry us through autumn and winter if possible. We will retest end of April when we see our endocrinologist and wait for the results and decide then. As you wrote if the antibodies are dropping I would be more likely to get the second booster sooner vs later. In the meantime wearing masks and physically distancing as best we can so hopefully our risks are low anyway. I was onboard with getting the first three as soon as we could but I feel less anxious to get this second booster for the reasons I listed.

Our timing is the same. I want to wait two months since my last antibody test. S will get his at the same time. It will be his first. We’ll go from there. I feel like we are all flying blind. There’s so much conflicting information..

 

[seaurchin]

Our timing is the same. I want to wait two months since my last antibody test. S will get his at the same time. It will be his first. We’ll go from there. I feel like we are all flying blind. There’s so much conflicting information..

Me too. That's one reason I just got it as soon as I could. Now at least I can stop thinking about it for a while!

 

[Calliecake]

i just read an interesting article from The New York Times called “A New Wave of Covid-19 Is Coming. Here’s how to Prepare.”

@MamaBee and @seaurchin , I think you might find this article very informative. it appeared in my news feed.

@Karl_K, You may want to ask your doctor about a drug called Evusheld (an AstraZeneca drug) given by injection to provide an additional layer of protection on top of vaccines for people who are at high risk.

 

[TooPatient]

I was offered a pneumonia vaccine when I went in to get my second Covid-19 booster so I got that too. I didn't even know pneumonia vaccines were a thing.

Altogether for the Covid-19 vaccinations, I got Moderna 3x and Pfizer 1x (for my first booster). I just took whatever was available at the time.

Anyway, if anyone else doesn't know, pneumonia vaccines are now a thing!

Just a heads up that you can still get pneumonia even vaccinated. There is a second vaccine you will need after whatever the time length is. There are also various strains of pneumonia. Pretty sure there are bacterial and viral pneumonia....
I had pneumonia at the time I learned all this so a bit vague on details. Told DH that he doesn't have to share EVERYTHING with me. I mean, he could have kept the dang pneumonia to himself

 

[TooPatient]

@missy We’re going to get an antibody test near April 22. That would be two months since my last antibody test. We’ll decide then…If they are high enough we will push it out. I may even get another antibody test during the summer. It would give me peace of mind if my antibodies are still high enough. If mine dropped like a brick..I‘ll get the booster. My husband has his eye on going to games in the fall. He wants to push it way out. We’ll see..

One thing I am looking at too is the likely possibility of another booster to come. I wish we knew what was ahead! If another is available in September/October, getting this one now would mean (probably) able to do that one then for maximum protection over summer and fall. Of course if they don't get another out until November/December/January or later, it wouldn't help his games....

 

[MamaBee]

One thing I am looking at too is the likely possibility of another booster to come. I wish we knew what was ahead! If another is available in September/October, getting this one now would mean (probably) able to do that one then for maximum protection over summer and fall. Of course if they don't get another out until November/December/January or later, it wouldn't help his games....

I would love to get the omicron variant vaccine. I read that it probably wouldn’t be ready before the end of the year if at all. The data showed it didn’t help any more than the regular vaccine.